317 related articles for article (PubMed ID: 33935804)
1. MicroRNA as Potential Biomarkers of Platelet Function on Antiplatelet Therapy: A Review.
Czajka P; Fitas A; Jakubik D; Eyileten C; Gasecka A; Wicik Z; Siller-Matula JM; Filipiak KJ; Postula M
Front Physiol; 2021; 12():652579. PubMed ID: 33935804
[TBL] [Abstract][Full Text] [Related]
2. The role of miRNAs in regulation of platelet activity and related diseases - a bioinformatic analysis.
Wicik Z; Czajka P; Eyileten C; Fitas A; Wolska M; Jakubik D; von Lewinski D; Sourij H; Siller-Matula JM; Postula M
Platelets; 2022 Oct; 33(7):1052-1064. PubMed ID: 35285386
[TBL] [Abstract][Full Text] [Related]
3. microRNAs as promising biomarkers of platelet activity in antiplatelet therapy monitoring.
Krammer TL; Mayr M; Hackl M
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32423125
[TBL] [Abstract][Full Text] [Related]
4. Circulating microRNAs as biomarkers and mediators of platelet activation.
Gutmann C; Mayr M
Platelets; 2022 May; 33(4):512-519. PubMed ID: 35264060
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA Biomarkers and Platelet Reactivity: The Clot Thickens.
Sunderland N; Skroblin P; Barwari T; Huntley RP; Lu R; Joshi A; Lovering RC; Mayr M
Circ Res; 2017 Jan; 120(2):418-435. PubMed ID: 28104774
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Characterization of Platelet-Enriched MicroRNAs as Biomarkers of Platelet Activation.
Krammer TL; Zeibig S; Schrottmaier WC; Pirabe A; Goebel S; Diendorfer AB; Holthoff HP; Assinger A; Hackl M
Cells; 2022 Apr; 11(8):. PubMed ID: 35455934
[TBL] [Abstract][Full Text] [Related]
7. Do miRNAs Have a Role in Platelet Function Regulation?
Garcia A; Dunoyer-Geindre S; Fontana P
Hamostaseologie; 2021 Jun; 41(3):217-224. PubMed ID: 34192780
[TBL] [Abstract][Full Text] [Related]
8. Association of MicroRNAs and YRNAs With Platelet Function.
Kaudewitz D; Skroblin P; Bender LH; Barwari T; Willeit P; Pechlaner R; Sunderland NP; Willeit K; Morton AC; Armstrong PC; Chan MV; Lu R; Yin X; Gracio F; Dudek K; Langley SR; Zampetaki A; de Rinaldis E; Ye S; Warner TD; Saxena A; Kiechl S; Storey RF; Mayr M
Circ Res; 2016 Feb; 118(3):420-432. PubMed ID: 26646931
[TBL] [Abstract][Full Text] [Related]
9. Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review.
Pordzik J; Jakubik D; Jarosz-Popek J; Wicik Z; Eyileten C; De Rosa S; Indolfi C; Siller-Matula JM; Czajka P; Postula M
Cardiovasc Diabetol; 2019 Aug; 18(1):113. PubMed ID: 31470851
[TBL] [Abstract][Full Text] [Related]
10. Role of miRNAs on the Pathophysiology of Cardiovascular Diseases.
Silva DCPD; Carneiro FD; Almeida KC; Fernandes-Santos C
Arq Bras Cardiol; 2018 Nov; 111(5):738-746. PubMed ID: 30484515
[TBL] [Abstract][Full Text] [Related]
11. Platelets in Acute Coronary Syndrome Patients with High Platelet Reactivity after Dual Antiplatelet Therapy Exhibit Upregulation of miR-204-5p.
Ding T; Zeng X; Cheng B; Ma X; Yuan H; Nie X; Gong M; Zhang H
Ann Clin Lab Sci; 2019 Sep; 49(5):619-631. PubMed ID: 31611205
[TBL] [Abstract][Full Text] [Related]
12. Circulating and Platelet MicroRNAs in Cardiovascular Risk Assessment and Antiplatelet Therapy Monitoring.
Procyk G; Klimczak-Tomaniak D; Sygitowicz G; Tomaniak M
J Clin Med; 2022 Mar; 11(7):. PubMed ID: 35407371
[TBL] [Abstract][Full Text] [Related]
13. Platelet miRNAs and cardiovascular diseases.
Fuentes E; Palomo I; Alarcón M
Life Sci; 2015 Jul; 133():29-44. PubMed ID: 26003375
[TBL] [Abstract][Full Text] [Related]
14. Small RNAs as potential platelet therapeutics.
Edelstein LC; Bray PF
Handb Exp Pharmacol; 2012; (210):435-45. PubMed ID: 22918741
[TBL] [Abstract][Full Text] [Related]
15. Platelet MicroRNA 365-3p Expression Correlates with High On-treatment Platelet Reactivity in Coronary Artery Disease Patients.
Chen YC; Lin FY; Lin YW; Cheng SM; Chang CC; Lin RH; Chuang CL; Sheu JS; Chen SM; Tsai CS
Cardiovasc Drugs Ther; 2019 Apr; 33(2):129-137. PubMed ID: 30783954
[TBL] [Abstract][Full Text] [Related]
16. The Potential Role of Platelet-Related microRNAs in the Development of Cardiovascular Events in High-Risk Populations, Including Diabetic Patients: A Review.
Pordzik J; Pisarz K; De Rosa S; Jones AD; Eyileten C; Indolfi C; Malek L; Postula M
Front Endocrinol (Lausanne); 2018; 9():74. PubMed ID: 29615970
[TBL] [Abstract][Full Text] [Related]
17. [microRNA and internal medicine: from pathophysiology to the new diagnostic and therapeutic procedures].
Novak J; Souček M
Vnitr Lek; 2016; 62(6):477-85. PubMed ID: 27485847
[TBL] [Abstract][Full Text] [Related]
18. Utility of circulating microRNAs as clinical biomarkers for cardiovascular diseases.
Kondkar AA; Abu-Amero KK
Biomed Res Int; 2015; 2015():821823. PubMed ID: 25710029
[TBL] [Abstract][Full Text] [Related]
19. Circulating microRNAs in cardiovascular diseases: from biomarkers to therapeutic targets.
Wang F; Chen C; Wang D
Front Med; 2014 Dec; 8(4):404-18. PubMed ID: 25445171
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA and Cardiovascular Diseases.
Çakmak HA; Demir M
Balkan Med J; 2020 Feb; 37(2):60-71. PubMed ID: 32018347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
